Behavioral and electrophysiological evidence for tolerance to continuous morphine administration into the

D A Lane1, V Tortorici, M M Morgan

  • 1Washington State University Vancouver, 14204 Northeast Salmon Creek Avenue, Vancouver, WA 98686, USA.

Neuroscience
|March 31, 2004
PubMed

Insights

Continuous morphine administration into the ventrolateral periaqueductal gray (vPAG) causes tolerance to its pain-relieving effects. This tolerance results from direct actions of morphine on vPAG neurons, not procedural cues.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Repeated morphine microinjections into the ventrolateral periaqueductal gray (vPAG) induce tolerance to antinociception.
  • This tolerance could stem from direct drug effects or associative learning linked to the injection procedure.

Purpose of the Study:

  • To investigate if continuous morphine administration into the vPAG, without procedural cues, leads to tolerance.
  • To differentiate between direct pharmacological tolerance and associative tolerance.

Main Methods:

  • Rats received continuous morphine (2.5 or 5 microg/h) or saline via osmotic minipumps into the vPAG.
  • Tolerance was assessed behaviorally (hotplate test) and electrophysiologically by monitoring rostral ventromedial medulla (RVM) neuronal activity.

Main Results:

  • Continuous vPAG morphine administration induced antinociception, with tolerance developing within 24 hours.
  • After 3 days, RVM on- and off-cell activity remained normal, but systemic naloxone caused hyperalgesia, indicating functional opioid withdrawal.
  • Behavioral and electrophysiological data confirmed tolerance due to direct morphine action on vPAG neurons.

Conclusions:

  • Continuous morphine delivery to the vPAG causes tolerance independent of injection-associated cues.
  • Tolerance to morphine's antinociceptive effects is mediated by direct actions on vPAG neurons.